[1] Rudi J, Kuck D, Rudy A, Sieg A, Maiwald M, Stremmel W. Helicobacter pylori vacA genotypes and cagA gene in a series of 383 H.pylori-positive patients. Z Gastroenterol, 2000, 38(7): 559-564.[2] Ahmad A, Govil Y, Frank BB. Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gsatroenterol, 2003, 98(5): 975-986.[3] Olivares D, Gisbert JP. Factors involved in the pathogenesis of Helicobacter pylori infection. Rev Esp Enferm Dig, 2006, 98(5): 374-386.[4] Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res, 2003, 63(5): 951-957.[5] Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecular characterization of the 128 kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA, 1993, 90(12): 5791-5795.[6] Peek RM Jr, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol, 2006, 208(2): 233-248.[7] Ando T, Goto Y, Maeda O, Watanabe O, Ishiguro K, Goto H. Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol, 2006, 12(2): 181-186.[8] Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol, 1995, 48(1): 41-45.[9] Crabtree JE, Farmery SM, Lindley IJ, Figura N, Peichl P, Tompkins DS. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol, 1994, 47(10): 945-950.[10] Sharma SA, Tummuru MK, Miller GG, Blaser MJ. Inter-leukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun, 1995, 63(5): 1681-1687.[11] Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology, 1996, 110(6): 1744-1752.[12] Peek RM, Miller GG, Tham KT, Perez-Perez GI, Zhao XM, Atherton JC, Blaser J. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest, 1995, 73(6): 760-770.[13] Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet, 1991, 338(8763): 332-335.[14] Weel JFL, van der Hulst RWM, Gerrits Y, Roorda P, Feller M, Dankert J, Tytgat GNJ, van der Ende A. The interrela-tionship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis, 1996, 173(5): 1171-1175.[15] Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 1997, 40(3): 297-301.[16] Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res, 1995, 55(10): 2111-2115.[17] Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN, Morgan AG. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut, 1993, 34(10): 1339-1343.[18] Li J, Ou ZY, Wang FJ, Guo Y, Zhang R, Zhang J, Li PQ, Xu WJ, He YS. Distinctiveness of the cagA geno-type in children and adults with peptic symptoms in South China.
|